2024-03-28 11:37:10 ET
Aspira Women's Health Inc. (AWH)
Q4 2023 Results Conference Call
March 28, 2024 08:30 AM ET
Company Participants
Nicole Sandford - President and Chief Executive Officer
Torsten Hombeck - Chief Financial Officer
Conference Call Participants
Ross Osborn - Cantor Fitzgerald
Sally Yanchus - Water Tower Research
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to Aspira Women's Health, Incorporated. Fourth Quarter and '23 Year-end Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded today. Leading the call today are Nicole Sandford, Chief Executive Officer; and Torsten Hombeck, Chief Financial Officer.
Before we begin, I would like to remind everyone that forward-looking statements, as defined under the Private Securities Litigation Reform Act of 1995, will be made during this call, including statements relating to Aspira's expected future performance future performance, future business prospects and future events or plans.
Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual outcomes and results are subject to risks and uncertainties and could differ materially from those anticipated due to the impact of many factors beyond Aspira Women's Health's control.
The company assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Participants are directed to the cautionary note set forth in today's press release as well as the risk factors set forth in Aspira's most recent annual report on Form 10-K and quarterly report on Form 10-Q filed with the SEC. For a description of factors that could cause actual results to differ materially from those anticipated in the forward-looking statements....
Read the full article on Seeking Alpha
For further details see:
Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript